Contact
Print
Respiratory
PSI is a leading full-service CRO operating globally.
98% of PSI-managed clinical trials complete patient enrollment on or ahead of schedule.
PSI's exceptional repeat and referral business rate distinguishes PSI in the market place as a "no-nonsense" CRO that delivers across trials of all sizes and levels of complexity.
PSI has successfully performed Phase II/III studies in the following respiratory indications:
- Acute bronchitis
- ARDS
- COPD
- Asthma
- Adult
- Paediatric
- Cystic Fibrosis
- Lung cancer
- Neonatal RDS
- Pneumonia
- CAP
- HAP
PSI employs physicians as full-time monitors and project managers, most of whom are board certified specialists, including pulmonologists, critical care specialists, and neonatologists.